The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions
- 30 September 1995
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 173 (3) , 913-917
- https://doi.org/10.1016/0002-9378(95)90365-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The effect of the oxytocin antagonist atosiban on preterm uterine activity in the humanAmerican Journal of Obstetrics and Gynecology, 1994
- Pharmacokinetic properties of the tocolytic agent [Mpa1d‐Tyr(Et)2, Thr4, Orn8]‐oxytocin (antocin) in healthy volunteersClinical Endocrinology, 1993
- Oxytocin Receptor Blockade: A New Principle in the Treatment of Preterm Labor?American Journal of Perinatology, 1989
- Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot studyBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Evaluation of 1-deamino-[D-Tyr(Oethyl)2, Thr4, Orn8] vasotocin, an oxytocin antagonist in animal models of uterine contractility and preterm labor: A new tocolytic agentAmerican Journal of Obstetrics and Gynecology, 1987
- Synthetic antagonists of the myometrial response to vasopressin and oxytocinJournal of Endocrinology, 1986
- Pharmacokinetics in the human of a new synthetic vasopressin and oxytocin uterine antagonistActa Endocrinologica, 1986